Discovery of a non‐nucleotide stimulator of interferon genes (STING) agonist with systemic antitumor effect

Abstract excerpt

Agonists of the stimulator of interferon genes (STING) pathway are increasingly being recognized as a promising new approach in the treatment of cancer. Although progress in clinical trials for STING agonists in antitumor applications has been slow, there is still an urgent need for developing new potent STING agonists with versatile potential applications. Herein, we developed and identified a non-nucleotide...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Immune Response and Inflammation
• Share to interferon and immune responses
• Share to Viral Infections and Vectors